Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Immunopharmacology

Results: 76-100/800

Authors: Matsuda, S Koyasu, S
Citation: S. Matsuda et S. Koyasu, Mechanisms of action of cyclosporine, IMMUNOPHARM, 47(2-3), 2000, pp. 119-125

Authors: Souness, JE Aldous, D Sargent, C
Citation: Je. Souness et al., Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors, IMMUNOPHARM, 47(2-3), 2000, pp. 127-162

Authors: Sintchak, MD Nimmesgern, E
Citation: Md. Sintchak et E. Nimmesgern, The structure of inosine 5 '-monophosphate dehydrogenase and the design ofnovel inhibitors, IMMUNOPHARM, 47(2-3), 2000, pp. 163-184

Authors: Lee, JC Kumar, S Griswold, DE Underwood, DC Votta, BJ Adams, JL
Citation: Jc. Lee et al., Inhibition of p38 MAP kinase as a therapeutic strategy, IMMUNOPHARM, 47(2-3), 2000, pp. 185-201

Authors: Assmann, T Homey, B Ruzicka, T
Citation: T. Assmann et al., Applications of tacrolimus for the treatment of skin disorders, IMMUNOPHARM, 47(2-3), 2000, pp. 203-213

Authors: Mele, TS Halloran, PF
Citation: Ts. Mele et Pf. Halloran, The use of mycophenolate mofetil in transplant recipients, IMMUNOPHARM, 47(2-3), 2000, pp. 215-245

Authors: Genestier, L Paillot, R Quemeneur, L Izeradjene, K Revillard, JP
Citation: L. Genestier et al., Mechanisms of action of methotrexate, IMMUNOPHARM, 47(2-3), 2000, pp. 247-257

Authors: Alarcon, GS
Citation: Gs. Alarcon, Methotrexate use in rheumatoid arthritis. A clinician's perspective, IMMUNOPHARM, 47(2-3), 2000, pp. 259-271

Authors: Herrmann, ML Schleyerbach, R Kirschbaum, BJ
Citation: Ml. Herrmann et al., Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases, IMMUNOPHARM, 47(2-3), 2000, pp. 273-289

Authors: Schattenkirchner, M
Citation: M. Schattenkirchner, The use of leflunomide in the treatment of rheumatoid arthritis: an experimental and clinical review, IMMUNOPHARM, 47(2-3), 2000, pp. 291-298

Authors: Hugli, TE
Citation: Te. Hugli, Immunosuppressive drugs, IMMUNOPHARM, 47(2-3), 2000, pp. V-V

Authors: Calabrese, KS Paradela, ASRC do Valle, TZ Tedesco, RC Silva, S Mortara, RA da Costa, SCG
Citation: Ks. Calabrese et al., Study of acute chagasic mice under immunosuppressive therapy by cyclosporin A: modulation and confocal analysis of inflammatory reaction, IMMUNOPHARM, 47(1), 2000, pp. 1-11

Authors: Furie, MB Raffanello, JA Gergel, EI Lisinski, TJ Horb, LD
Citation: Mb. Furie et al., Extracts of smokeless tobacco induce pro-inflammatory changes in cultured human vascular endothelial cells, IMMUNOPHARM, 47(1), 2000, pp. 13-23

Authors: Nagy, E Mihalik, R Hrabak, A Vertesi, C Gergely, P
Citation: E. Nagy et al., Apoptosis inhibitory effect of the isothiourea compound, tri-(2-thioureido-S-ethyl)-amine, IMMUNOPHARM, 47(1), 2000, pp. 25-33

Authors: Sung, JY Hong, JH Kang, HS Choi, I Lim, SD Lee, JK Seok, JH Lee, JH Hur, GM
Citation: Jy. Sung et al., Methotrexate suppresses the interleukin-6 induced generation of reactive oxygen species in the synoviocytes of rheumatoid arthritis, IMMUNOPHARM, 47(1), 2000, pp. 35-44

Authors: Burger, RA Billingsley, JL Huffman, JH Bailey, KW Kim, CU Sidwell, RW
Citation: Ra. Burger et al., Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice, IMMUNOPHARM, 47(1), 2000, pp. 45-52

Authors: Miyagi, T Chuang, LF Lam, KM Kung, HF Wang, JM Osburn, BI Chuang, RY
Citation: T. Miyagi et al., Opioids suppress chemokine-mediated migration of monkey neutrophils and monocytes - an instant response, IMMUNOPHARM, 47(1), 2000, pp. 53-62

Authors: Lysle, DT How, T
Citation: Dt. Lysle et T. How, Heroin modulates the expression of inducible nitric oxide synthase, IMMUNOPHARM, 46(3), 2000, pp. 181-192

Authors: Fecho, K Nelson, CJ Lysle, DT
Citation: K. Fecho et al., Phenotypic and functional assessments of immune status in the rat spleen following acute heroin treatment, IMMUNOPHARM, 46(3), 2000, pp. 193-207

Authors: Jagels, MA Daffern, PJ Hugli, TE
Citation: Ma. Jagels et al., C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion, IMMUNOPHARM, 46(3), 2000, pp. 209-222

Authors: Conner, TJ Kelly, JP Leonard, BE
Citation: Tj. Conner et al., An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats, IMMUNOPHARM, 46(3), 2000, pp. 223-235

Authors: Costa, RH Casarini, DE Plavnik, FL Marson, O Alves, KB
Citation: Rh. Costa et al., Angiotensin converting-like enzymes from urine of untreated renovascular hypertensive and normal patients: purification and characterization, IMMUNOPHARM, 46(3), 2000, pp. 237-246

Authors: Helgason, CM Frank, JLW Johnson, DR Frank, MG Hendricks, SE
Citation: Cm. Helgason et al., The effects of St. John's Wort (Hypericum perforatum) on NK cell activity in vitro, IMMUNOPHARM, 46(3), 2000, pp. 247-251

Authors: Krakauer, T
Citation: T. Krakauer, Pentoxifylline inhibits ICAM-1 expression and chemokine production inducedby proinflammatory cytokines in human pulmonary epithelial cells, IMMUNOPHARM, 46(3), 2000, pp. 253-261

Authors: Guest, I Uetrecht, J
Citation: I. Guest et J. Uetrecht, Drugs toxic to the bone marrow that target the stromal cells, IMMUNOPHARM, 46(2), 2000, pp. 103-112
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>